In pulmonary embolism , fibrinolytic therapy is responsible for
Hemorrhage is the main complication of fibrinolytic therapy, so it is contraindicated in all situations where the risk of bleeding is increased - recent trauma, surgery, biopsies, stroke, peptic ulcer, aneurysms, bleeding disorders, diabetes, acute pancreatitis etc.)
Massive emboli
Risk of hemorrhage
All the above
None of the above
Cardio thoracic surgery  